CompuMed, Inc. (CMPD)
USD 3.53
(-1.94%)
USD 3.53
(-1.94%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -31.2 Thousand USD | -105.67% |
| 2022 | 550.45 Thousand USD | -45.68% |
| 2021 | 1.01 Million USD | 156.81% |
| 2020 | 394.63 Thousand USD | -60.32% |
| 2019 | 994.49 Thousand USD | 335.87% |
| 2018 | 228.16 Thousand USD | 150.18% |
| 2017 | 91.2 Thousand USD | 177.22% |
| 2016 | -118.11 Thousand USD | 0.0% |
| 2011 | -302 Thousand USD | 13.22% |
| 2010 | -348 Thousand USD | -72.28% |
| 2009 | -202 Thousand USD | 85.46% |
| 2008 | -1.38 Million USD | -29.09% |
| 2007 | -1.07 Million USD | -137.53% |
| 2006 | -453 Thousand USD | -24.45% |
| 2005 | -364 Thousand USD | -3.7% |
| 2004 | -351 Thousand USD | 16.82% |
| 2003 | -422 Thousand USD | 30.59% |
| 2002 | -608 Thousand USD | 36.2% |
| 2001 | -953 Thousand USD | 40.14% |
| 2000 | -1.59 Million USD | -44.73% |
| 1999 | -1.1 Million USD | 35.29% |
| 1998 | -1.7 Million USD | 26.09% |
| 1997 | -2.3 Million USD | -35.29% |
| 1996 | -1.7 Million USD | -13.33% |
| 1995 | -1.5 Million USD | 25.0% |
| 1994 | -2 Million USD | 0.0% |
| 1993 | -2 Million USD | 4.76% |
| 1992 | -2.1 Million USD | -133.33% |
| 1991 | -900 Thousand USD | -12.5% |
| 1990 | -800 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1450.00 USD | 95.86% |
| 2024 Q3 | 105.07 Thousand USD | 43.97% |
| 2024 Q2 | 72.98 Thousand USD | 5133.1% |
| 2023 Q2 | -17.3 Thousand USD | -326.14% |
| 2023 FY | -31.2 Thousand USD | -105.67% |
| 2023 Q4 | -35.01 Thousand USD | -360.3% |
| 2023 Q3 | 13.45 Thousand USD | 177.75% |
| 2023 Q1 | 7650.00 USD | -96.82% |
| 2022 Q4 | 240.66 Thousand USD | 77.13% |
| 2022 Q2 | 53.15 Thousand USD | -55.99% |
| 2022 Q1 | 120.77 Thousand USD | -75.62% |
| 2022 Q3 | 135.87 Thousand USD | 155.63% |
| 2022 FY | 550.45 Thousand USD | -45.68% |
| 2021 Q3 | 250.51 Thousand USD | 56.78% |
| 2021 Q4 | 495.3 Thousand USD | 97.72% |
| 2021 FY | 1.01 Million USD | 156.81% |
| 2021 Q2 | 159.78 Thousand USD | 0.0% |
| 2020 FY | 394.63 Thousand USD | -60.32% |
| 2019 FY | 994.49 Thousand USD | 335.87% |
| 2018 FY | 228.16 Thousand USD | 150.18% |
| 2017 FY | 91.2 Thousand USD | 177.22% |
| 2016 FY | -118.11 Thousand USD | 0.0% |
| 2011 Q4 | -43 Thousand USD | -16.22% |
| 2011 FY | -302 Thousand USD | 13.22% |
| 2011 Q3 | -37 Thousand USD | 59.78% |
| 2011 Q1 | -130 Thousand USD | -120.34% |
| 2011 Q2 | -92 Thousand USD | 29.23% |
| 2010 FY | -348 Thousand USD | -72.28% |
| 2010 Q1 | -146 Thousand USD | -186.27% |
| 2010 Q2 | -61 Thousand USD | 58.22% |
| 2010 Q3 | -82 Thousand USD | -34.43% |
| 2010 Q4 | -59 Thousand USD | 28.05% |
| 2009 Q2 | 12 Thousand USD | 109.76% |
| 2009 FY | -202 Thousand USD | 85.46% |
| 2009 Q3 | -40 Thousand USD | -433.33% |
| 2009 Q4 | -51 Thousand USD | -27.5% |
| 2009 Q1 | -123 Thousand USD | 56.07% |
| 2008 FY | -1.38 Million USD | -29.09% |
| 2008 Q4 | -280 Thousand USD | -104.38% |
| 2008 Q3 | -137 Thousand USD | 75.8% |
| 2008 Q2 | -566 Thousand USD | -39.41% |
| 2008 Q1 | -406 Thousand USD | 22.52% |
| 2007 Q2 | -119 Thousand USD | 50.21% |
| 2007 FY | -1.07 Million USD | -137.53% |
| 2007 Q4 | -524 Thousand USD | -170.1% |
| 2007 Q3 | -194 Thousand USD | -63.03% |
| 2007 Q1 | -239 Thousand USD | -55.19% |
| 2006 Q1 | -34 Thousand USD | 78.48% |
| 2006 Q3 | -133 Thousand USD | -33.0% |
| 2006 FY | -453 Thousand USD | -24.45% |
| 2006 Q4 | -154 Thousand USD | -15.79% |
| 2006 Q2 | -100 Thousand USD | -194.12% |
| 2005 Q3 | -70 Thousand USD | -125.81% |
| 2005 FY | -364 Thousand USD | -3.7% |
| 2005 Q4 | -158 Thousand USD | -125.71% |
| 2005 Q1 | -105 Thousand USD | -0.96% |
| 2005 Q2 | -31 Thousand USD | 70.48% |
| 2004 Q2 | -111 Thousand USD | -63.24% |
| 2004 Q4 | -104 Thousand USD | -52.94% |
| 2004 Q3 | -68 Thousand USD | 38.74% |
| 2004 Q1 | -68 Thousand USD | 46.46% |
| 2004 FY | -351 Thousand USD | 16.82% |
| 2003 Q4 | -127 Thousand USD | -95.38% |
| 2003 FY | -422 Thousand USD | 30.59% |
| 2003 Q2 | -73 Thousand USD | 53.5% |
| 2003 Q1 | -157 Thousand USD | -118.06% |
| 2003 Q3 | -65 Thousand USD | 10.96% |
| 2002 FY | -608 Thousand USD | 36.2% |
| 2002 Q3 | -292 Thousand USD | -217.39% |
| 2002 Q4 | -72 Thousand USD | 75.34% |
| 2002 Q1 | -152 Thousand USD | 6.17% |
| 2002 Q2 | -92 Thousand USD | 39.47% |
| 2001 FY | -953 Thousand USD | 40.14% |
| 2001 Q4 | -162 Thousand USD | -28.57% |
| 2001 Q3 | -126 Thousand USD | 50.59% |
| 2001 Q2 | -255 Thousand USD | 37.8% |
| 2001 Q1 | -410 Thousand USD | 35.64% |
| 2000 Q3 | -468 Thousand USD | -91.8% |
| 2000 FY | -1.59 Million USD | -44.73% |
| 2000 Q2 | -244 Thousand USD | 18.67% |
| 2000 Q4 | -637 Thousand USD | -36.11% |
| 2000 Q1 | -300 Thousand USD | 0.0% |
| 1999 Q2 | -200 Thousand USD | 33.33% |
| 1999 FY | -1.1 Million USD | 35.29% |
| 1999 Q4 | -300 Thousand USD | -50.0% |
| 1999 Q3 | -200 Thousand USD | 0.0% |
| 1999 Q1 | -300 Thousand USD | 40.0% |
| 1998 Q1 | -600 Thousand USD | 14.29% |
| 1998 FY | -1.7 Million USD | 26.09% |
| 1998 Q4 | -500 Thousand USD | -25.0% |
| 1998 Q3 | -400 Thousand USD | 0.0% |
| 1998 Q2 | -400 Thousand USD | 33.33% |
| 1997 Q4 | -700 Thousand USD | -40.0% |
| 1997 Q3 | -500 Thousand USD | 28.57% |
| 1997 Q2 | -700 Thousand USD | -40.0% |
| 1997 Q1 | -500 Thousand USD | -66.67% |
| 1997 FY | -2.3 Million USD | -35.29% |
| 1996 Q2 | -700 Thousand USD | -16.67% |
| 1996 FY | -1.7 Million USD | -13.33% |
| 1996 Q1 | -600 Thousand USD | 0.0% |
| 1996 Q4 | -300 Thousand USD | 0.0% |
| 1996 Q3 | -300 Thousand USD | 57.14% |
| 1995 Q1 | 800 Thousand USD | 300.0% |
| 1995 FY | -1.5 Million USD | 25.0% |
| 1995 Q3 | -300 Thousand USD | 25.0% |
| 1995 Q4 | -600 Thousand USD | -100.0% |
| 1995 Q2 | -400 Thousand USD | -150.0% |
| 1994 Q3 | -500 Thousand USD | 44.44% |
| 1994 Q4 | -400 Thousand USD | 20.0% |
| 1994 Q2 | -900 Thousand USD | -200.0% |
| 1994 Q1 | -300 Thousand USD | 40.0% |
| 1994 FY | -2 Million USD | 0.0% |
| 1993 Q3 | -300 Thousand USD | -130.0% |
| 1993 Q4 | -500 Thousand USD | -66.67% |
| 1993 FY | -2 Million USD | 4.76% |
| 1993 Q2 | 1 Million USD | 42.86% |
| 1993 Q1 | 700 Thousand USD | 114.0% |
| 1992 Q1 | 1 Million USD | 125.0% |
| 1992 FY | -2.1 Million USD | -133.33% |
| 1992 Q4 | -5 Million USD | -725.0% |
| 1992 Q2 | -700 Thousand USD | -170.0% |
| 1992 Q3 | 800 Thousand USD | 214.29% |
| 1991 Q4 | -4 Million USD | -463.64% |
| 1991 Q1 | -100 Thousand USD | 97.3% |
| 1991 Q2 | 1 Million USD | 1100.0% |
| 1991 FY | -900 Thousand USD | -12.5% |
| 1991 Q3 | 1.1 Million USD | 10.0% |
| 1990 Q1 | 900 Thousand USD | 0.0% |
| 1990 FY | -800 Thousand USD | 0.0% |
| 1990 Q3 | 1 Million USD | 0.0% |
| 1990 Q4 | -3.7 Million USD | -470.0% |
| 1990 Q2 | 1 Million USD | 11.11% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Achiko AG | -8.35 Million USD | 99.627% |
| Accelera Innovations, Inc | - USD | Infinity% |
| Aspyra Inc. | 4.7 Million USD | 100.663% |
| Cannabis Sativa, Inc. | -855.85 Thousand USD | 96.354% |
| CompuGroup Medical SE & Co. KGaA | 171.25 Million USD | 100.018% |
| Cogstate Limited | 660.18 Thousand USD | 104.726% |
| CareView Communications, Inc. | -688.3 Thousand USD | 95.467% |
| Craneware plc | 19.73 Million USD | 100.158% |
| Caduceus Software Systems Corp. | -1.15 Million USD | 97.297% |
| Certive Solutions Inc. | -2.1 Million USD | 98.515% |
| Drug Free Solution, Inc. | -1.4 Million USD | 97.783% |
| DATATRAK International, Inc. | 1.87 Million USD | 101.661% |
| Strainsforpains, Inc. | -65.61 Thousand USD | 52.443% |
| Healixa Inc. | -6.35 Million USD | 99.509% |
| Easy Technologies Inc. | - USD | Infinity% |
| eWellness Healthcare Corporation | - USD | Infinity% |
| Founders Bay Holdings | 9.02 Million USD | 100.346% |
| Health Discovery Corporation | - USD | Infinity% |
| Healthcare Integrated Technologies, Inc. | -983.56 Thousand USD | 96.828% |
| H-Source Holdings Ltd. | - USD | Infinity% |
| InterCare DX, Inc. | -789.33 USD | -3852.973% |
| IQ-AI Limited | -517.25 Thousand USD | 93.968% |
| Cannabiz Mobile, Inc. | -750.00 USD | -4060.267% |
| Mednow Inc. | -17.04 Million USD | 99.817% |
| Galileo Life Sciences, Inc. | -271.37 Thousand USD | 88.502% |
| MediXall Group, Inc. | -6.54 Million USD | 99.523% |
| Mitesco, Inc. | -2.58 Million USD | 98.794% |
| MobileSmith, Inc. | -7.81 Million USD | 99.601% |
| NantHealth, Inc. | -51.32 Million USD | 99.939% |
| Net Medical Xpress Solutions, Inc. | -1.82 Million USD | 98.287% |
| OneLife Technologies Corp. | - USD | Infinity% |
| ORHub, Inc. | -12.15 Million USD | 99.743% |
| Patient Access Solutions, Inc. | -9 Million USD | 99.653% |
| Pharma-Bio Serv, Inc. | 1.11 Million USD | 102.792% |
| PPJ Healthcare Enterprises, Inc. | 74.72 Thousand USD | 141.754% |
| Medical Cannabis Payment Solutions, Inc. | -34.1 Thousand USD | 8.499% |
| Renalytix Plc | -29.6 Million USD | 99.895% |
| Revium Recovery Inc. | -679 Thousand USD | 95.405% |
| RYAH Group, Inc. | - USD | Infinity% |
| Carepay Inc. | 396.65 Thousand USD | 107.866% |
| Vaso Corporation | 4.19 Million USD | 100.744% |
| Vynleads, Inc. | -235.73 Thousand USD | 86.764% |